Alopecia – Drugs in Development, 2021

Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Alopecia – Drugs in Development, 2021, provides an overview of the Alopecia (Dermatology) pipeline landscape.

Alopecia is the partial or complete loss of hair especially on the scalp either in patches, on the entire head or over the entire body. Thinning hair is the most obvious symptom. The predisposing factors include allergies, irritants, toxins, burns, injuries, and infections.

Report Highlights

Global Markets Direct's Pharmaceutical and Healthcare latest pipeline guide Alopecia – Drugs in Development, 2021, provides comprehensive information on the therapeutics under development for Alopecia (Dermatology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.

The Alopecia (Dermatology) pipeline guide also reviews of key players involved in therapeutic development for Alopecia and features dormant and discontinued projects. The guide covers therapeutics under Development by Companies /Universities /Institutes, the molecules developed by Companies in Pre-Registration, Phase III, Phase II, Phase I, IND/CTA Filed, Preclinical and Discovery stages are 2, 7, 18, 6, 1, 24 and 15 respectively. Similarly, the Universities portfolio in Preclinical stages comprises 3 molecules, respectively.

Alopecia (Dermatology) pipeline guide helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. The guide is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Note: Certain content / sections in the pipeline guide may be removed or altered based on the availability and relevance of data.

Scope

– The pipeline guide provides a snapshot of the global therapeutic landscape of Alopecia (Dermatology).

– The pipeline guide reviews pipeline therapeutics for Alopecia (Dermatology) by companies and universities/research institutes based on information derived from company and industry-specific sources.

– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.

– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.

– The pipeline guide reviews key companies involved in Alopecia (Dermatology) therapeutics and enlists all their major and minor projects.

– The pipeline guide evaluates Alopecia (Dermatology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.

– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.

– The pipeline guide reviews latest news related to pipeline therapeutics for Alopecia (Dermatology)

Reasons to buy

- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

- Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

- Find and recognize significant and varied types of therapeutics under development for Alopecia (Dermatology).

- Classify potential new clients or partners in the target demographic.

- Develop tactical initiatives by understanding the focus areas of leading companies.

- Plan mergers and acquisitions meritoriously by identifying key players and it’s most promising pipeline therapeutics.

- Formulate corrective measures for pipeline projects by understanding Alopecia (Dermatology) pipeline depth and focus of Indication therapeutics.

- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.

- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from pipeline.

Companies mentioned

Aclaris Therapeutics Inc

Addpharma Inc

Alexion Pharmaceuticals Inc

Almirall SA

AnaptysBio Inc

AnTolRx Inc

Applied Biology Inc

Arena Pharmaceuticals Inc

Berg LLC

BiologicsMD Inc

Bioniz Therapeutics Inc

Bioquark Inc

Table of Contents

Table of Contents

Introduction

Alopecia - Overview

Alopecia - Therapeutics Development

Alopecia - Therapeutics Assessment

Alopecia - Companies Involved in Therapeutics Development

Alopecia - Drug Profiles

Alopecia - Dormant Projects

Alopecia - Discontinued Products

Alopecia - Product Development Milestones

Appendix

List of Tables

List of Tables

Number of Products under Development for Alopecia, 2021

Number of Products under Development by Companies, 2021

Number of Products under Development by Companies, 2021 (Contd..1)

Number of Products under Development by Companies, 2021 (Contd..2)

Number of Products under Development by Universities/Institutes, 2021

Products under Development by Companies, 2021

Products under Development by Companies, 2021 (Contd..1)

Products under Development by Companies, 2021 (Contd..2)

Products under Development by Companies, 2021 (Contd..3)

Products under Development by Companies, 2021 (Contd..4)

Products under Development by Universities/Institutes, 2021

Number of Products by Stage and Target, 2021

Number of Products by Stage and Target, 2021 (Contd..1)

Number of Products by Stage and Mechanism of Action, 2021

Number of Products by Stage and Mechanism of Action, 2021 (Contd..1)

Number of Products by Stage and Route of Administration, 2021

Number of Products by Stage and Molecule Type, 2021

Alopecia – Pipeline by Aclaris Therapeutics Inc, 2021

Alopecia – Pipeline by Addpharma Inc, 2021

Alopecia – Pipeline by Alexion Pharmaceuticals Inc, 2021

Alopecia – Pipeline by Almirall SA, 2021

Alopecia – Pipeline by AnaptysBio Inc, 2021

Alopecia – Pipeline by AnTolRx Inc, 2021

Alopecia – Pipeline by Applied Biology Inc, 2021

Alopecia – Pipeline by Arena Pharmaceuticals Inc, 2021

Alopecia – Pipeline by Berg LLC, 2021

Alopecia – Pipeline by BiologicsMD Inc, 2021

Alopecia – Pipeline by Bioniz Therapeutics Inc, 2021

Alopecia – Pipeline by Bioquark Inc, 2021

Alopecia – Pipeline by BirchBioMed Inc, 2021

Alopecia – Pipeline by BRIM Biotechnology Inc, 2021

Alopecia – Pipeline by CarthroniX Inc, 2021

Alopecia – Pipeline by Cassiopea SpA, 2021

Alopecia – Pipeline by Concert Pharmaceuticals Inc, 2021

Alopecia – Pipeline by Eli Lilly and Co, 2021

Alopecia – Pipeline by Energenesis Biomedical Co Ltd, 2021

Alopecia – Pipeline by Exicure Inc, 2021

Alopecia – Pipeline by Follica Inc, 2021

Alopecia – Pipeline by Follicum AB, 2021

Alopecia – Pipeline by Hangzhou Jitai Pharmaceutical Technology Co Ltd, 2021

Alopecia – Pipeline by Haplnscience Inc, 2021

Alopecia – Pipeline by HCell Inc, 2021

Alopecia – Pipeline by HCW Biologics Inc, 2021

Alopecia – Pipeline by Histogen Inc, 2021

Alopecia – Pipeline by Japan Tobacco Inc, 2021

Alopecia – Pipeline by Jiangsu Hengrui Medicine Co Ltd, 2021

Alopecia – Pipeline by JN Biosciences LLC, 2021

Alopecia – Pipeline by Johnson & Johnson, 2021

Alopecia – Pipeline by JW Pharmaceutical Corp, 2021

Alopecia – Pipeline by Kintor Pharmaceutical Ltd, 2021

Alopecia – Pipeline by Kuhnil Pharmaceutical Co Ltd, 2021

Alopecia – Pipeline by LG Chem Ltd, 2021

Alopecia – Pipeline by Maxinovel Pharmaceuticals, 2021

Alopecia – Pipeline by Mirae Cell Bio Co Ltd, 2021

Alopecia – Pipeline by Moogene Medi Inc, 2021

Alopecia – Pipeline by Nepsone ehf, 2021

Alopecia – Pipeline by OliX Pharmaceuticals Inc, 2021

Alopecia – Pipeline by Omega Therapeutics Inc, 2021

Alopecia – Pipeline by Pfizer Inc, 2021

Alopecia – Pipeline by Phio Pharmaceuticals Corp, 2021

Alopecia – Pipeline by Quark Pharmaceuticals Inc, 2021

Alopecia – Pipeline by RiverTown Therapeutics Inc, 2021

Alopecia – Pipeline by Samson Clinical Pty Ltd, 2021

Alopecia – Pipeline by Samumed LLC, 2021

Alopecia – Pipeline by Shenzhen Chipscreen Biosciences Co Ltd, 2021

Alopecia – Pipeline by siRNAgen Therapeutics Corp, 2021

Alopecia – Pipeline by Stemson Therapeutics Corp, 2021

Alopecia – Pipeline by Sun Pharmaceutical Industries Ltd, 2021

Alopecia – Pipeline by Suzhou Ribo Life Sciences Co Ltd, 2021

Alopecia – Pipeline by Suzhou Zelgen Biopharmaceutical Co Ltd, 2021

Alopecia – Pipeline by TagCyx Biotechnologies, 2021

Alopecia – Pipeline by Tigo GmbH, 2021

Alopecia – Pipeline by Triple Hair Inc, 2021

Alopecia – Pipeline by Tritech Biopharmaceuticals Co Ltd, 2021

Alopecia – Pipeline by VasoDynamics Ltd, 2021

Alopecia – Dormant Projects, 2021

Alopecia – Dormant Projects, 2021 (Contd..1)

Alopecia – Dormant Projects, 2021 (Contd..2)

Alopecia – Dormant Projects, 2021 (Contd..3)

Alopecia – Discontinued Products, 2021

List of Figures

List of Figures

Number of Products under Development for Alopecia, 2021

Number of Products under Development by Companies, 2021

Number of Products by Top 10 Targets, 2021

Number of Products by Stage and Top 10 Targets, 2021

Number of Products by Top 10 Mechanism of Actions, 2021

Number of Products by Stage and Top 10 Mechanism of Actions, 2021

Number of Products by Top 10 Routes of Administration, 2021

Number of Products by Stage and Top 10 Routes of Administration, 2021

Number of Products by Top 10 Molecule Types, 2021

Number of Products by Stage and Top 10 Molecule Types, 2021

    Pricing

Discounts available for multiple purchases.

reportstore@globalmarketsdirect.com
+44 20 7947 2745

Saved reports